PMC:6864571 / 4029-4378 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/6864571","sourcedb":"PMC","sourceid":"6864571","source_url":"https://www.ncbi.nlm.nih.gov/pmc/6864571","text":"Conclusion:\nWhole-exome sequencing and EP are the most cost-effective genetic tests for epilepsy. Our analyses support for a broad population of patients with unexplained epilepsy, starting with these tests. Although less expensive, CMA has lower yield, and its use as the first-tier test is thus not supported from a cost-effectiveness perspective.","divisions":[{"label":"title","span":{"begin":0,"end":11}}],"tracks":[]}